Kim M. Stegmann

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies

Thomas Güttler, Metin Aksu, Antje Dickmanns et al. · The EMBO Journal · 2021 · 104 citations · Full text

The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models

Kim M. Stegmann, Antje Dickmanns, Sabrina Gerber et al. · Virus Research · 2021 · 49 citations · Full text

Cell Culture Models, Immunology, Antiviral Drug Development +7

Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication

Kim M. Stegmann, Antje Dickmanns, Natalie Heinen et al. · iScience · 2022 · 38 citations · Full text

Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters

Metin Aksu, Priya Kumar, Thomas Güttler et al. · Antiviral Research · 2023 · 22 citations · Full text

Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design

Lisa-Marie Funk, Gereon Poschmann, Fabian Rabe von Pappenheim et al. · Nature Communications · 2024 · 22 citations · Full text